Publication | Closed Access

Comparison of the upper gastrointestinal safety of arthrotec® 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

Anti-inflammatoryGastrointestinal PharmacologyMedicineArthrotec® 75OsteoarthritisPharmacotherapyPharmacologyOsteoarthritis PatientsOrthopaedic SurgeryHigh Risk